nodes	percent_of_prediction	percent_of_DWPC	metapath
Nabumetone—osteoarthritis—Prednisone—atopic dermatitis	0.295	0.5	CpDpCtD
Nabumetone—osteoarthritis—Methylprednisolone—atopic dermatitis	0.295	0.5	CpDpCtD
Nabumetone—PTGS1—Diphenhydramine—atopic dermatitis	0.0791	0.296	CbGbCtD
Nabumetone—PTGS2—Triamcinolone—atopic dermatitis	0.0649	0.243	CbGbCtD
Nabumetone—PTGS2—Betamethasone—atopic dermatitis	0.0557	0.208	CbGbCtD
Nabumetone—CYP1A2—Diphenhydramine—atopic dermatitis	0.0353	0.132	CbGbCtD
Nabumetone—PTGS2—Dexamethasone—atopic dermatitis	0.0324	0.121	CbGbCtD
Nabumetone—MPO—IL23-mediated signaling events—IL18R1—atopic dermatitis	0.00203	0.209	CbGpPWpGaD
Nabumetone—PTGS2—Fluocinonide—Desonide—atopic dermatitis	0.000658	0.165	CbGdCrCtD
Nabumetone—MPO—IL23-mediated signaling events—IL17A—atopic dermatitis	0.000546	0.0562	CbGpPWpGaD
Nabumetone—PTGS2—Fluocinonide—Fluocinolone Acetonide—atopic dermatitis	0.000512	0.128	CbGdCrCtD
Nabumetone—PTGS2—Fluocinonide—Mometasone—atopic dermatitis	0.000409	0.102	CbGdCrCtD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—CABIN1—atopic dermatitis	0.000392	0.0403	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL18—atopic dermatitis	0.000373	0.0384	CbGpPWpGaD
Nabumetone—PTGS2—Fluticasone Propionate—Fluocinonide—atopic dermatitis	0.000318	0.0797	CbGdCrCtD
Nabumetone—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	0.000309	0.0774	CbGdCrCtD
Nabumetone—MPO—Vitamin B12 Metabolism—CCL5—atopic dermatitis	0.000288	0.0297	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—NFKBIA—atopic dermatitis	0.000285	0.0293	CbGpPWpGaD
Nabumetone—PTGS2—Fluticasone Propionate—Mometasone—atopic dermatitis	0.000247	0.0618	CbGdCrCtD
Nabumetone—PTGS2—Fluocinonide—Methylprednisolone—atopic dermatitis	0.000244	0.0612	CbGdCrCtD
Nabumetone—PTGS2—Fluocinonide—Betamethasone—atopic dermatitis	0.00024	0.0602	CbGdCrCtD
Nabumetone—PTGS2—Fluocinonide—Dexamethasone—atopic dermatitis	0.00024	0.0602	CbGdCrCtD
Nabumetone—PTGS2—Fluocinonide—Triamcinolone—atopic dermatitis	0.000235	0.0588	CbGdCrCtD
Nabumetone—MPO—Folate Metabolism—IL4—atopic dermatitis	0.000227	0.0234	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IFNG—atopic dermatitis	0.000218	0.0225	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—CD4—atopic dermatitis	0.000211	0.0217	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL1B—atopic dermatitis	0.000195	0.0201	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—IL2—atopic dermatitis	0.000194	0.02	CbGpPWpGaD
Nabumetone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—atopic dermatitis	0.000181	0.0186	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—atopic dermatitis	0.000177	0.0182	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.000169	0.0174	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.000151	0.0155	CbGpPWpGaD
Nabumetone—PTGS2—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	0.000147	0.0369	CbGdCrCtD
Nabumetone—PTGS2—Fluticasone Propionate—Betamethasone—atopic dermatitis	0.000145	0.0363	CbGdCrCtD
Nabumetone—PTGS2—Fluticasone Propionate—Dexamethasone—atopic dermatitis	0.000145	0.0363	CbGdCrCtD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—atopic dermatitis	0.000143	0.0147	CbGpPWpGaD
Nabumetone—PTGS2—Fluticasone Propionate—Triamcinolone—atopic dermatitis	0.000142	0.0355	CbGdCrCtD
Nabumetone—PTGS1—Overview of nanoparticle effects—CXCL8—atopic dermatitis	0.000142	0.0146	CbGpPWpGaD
Nabumetone—MPO—IL23-mediated signaling events—TNF—atopic dermatitis	0.000141	0.0146	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IFNG—atopic dermatitis	0.000137	0.0142	CbGpPWpGaD
Nabumetone—CYP1A2—Estrogen Receptor Pathway—PPARA—atopic dermatitis	0.000137	0.0141	CbGpPWpGaD
Nabumetone—Arrhythmia—Triamcinolone—atopic dermatitis	0.00013	0.00101	CcSEcCtD
Nabumetone—Weight decreased—Prednisone—atopic dermatitis	0.00013	0.00101	CcSEcCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—atopic dermatitis	0.00013	0.0134	CbGpPWpGaD
Nabumetone—Arrhythmia—Methylprednisolone—atopic dermatitis	0.00013	0.00101	CcSEcCtD
Nabumetone—Hypersensitivity—Tacrolimus—atopic dermatitis	0.00013	0.00101	CcSEcCtD
Nabumetone—Hyperglycaemia—Prednisone—atopic dermatitis	0.000129	0.001	CcSEcCtD
Nabumetone—Ill-defined disorder—Prednisolone—atopic dermatitis	0.000128	0.000991	CcSEcCtD
Nabumetone—Depression—Prednisone—atopic dermatitis	0.000128	0.00099	CcSEcCtD
Nabumetone—Visual impairment—Betamethasone—atopic dermatitis	0.000127	0.000987	CcSEcCtD
Nabumetone—Visual impairment—Dexamethasone—atopic dermatitis	0.000127	0.000987	CcSEcCtD
Nabumetone—Asthenia—Tacrolimus—atopic dermatitis	0.000126	0.000979	CcSEcCtD
Nabumetone—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000126	0.000979	CcSEcCtD
Nabumetone—Angioedema—Prednisolone—atopic dermatitis	0.000126	0.000976	CcSEcCtD
Nabumetone—Myocardial infarction—Prednisone—atopic dermatitis	0.000125	0.000974	CcSEcCtD
Nabumetone—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.000125	0.000968	CcSEcCtD
Nabumetone—Pruritus—Tacrolimus—atopic dermatitis	0.000124	0.000966	CcSEcCtD
Nabumetone—Malaise—Prednisolone—atopic dermatitis	0.000124	0.000963	CcSEcCtD
Nabumetone—Vertigo—Prednisolone—atopic dermatitis	0.000124	0.00096	CcSEcCtD
Nabumetone—Syncope—Prednisolone—atopic dermatitis	0.000123	0.000958	CcSEcCtD
Nabumetone—Angioedema—Hydrocortisone—atopic dermatitis	0.000123	0.000953	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—IL1B—atopic dermatitis	0.000123	0.0126	CbGpPWpGaD
Nabumetone—MPO—Folate Metabolism—IL2—atopic dermatitis	0.000122	0.0126	CbGpPWpGaD
Nabumetone—Malaise—Hydrocortisone—atopic dermatitis	0.000121	0.000941	CcSEcCtD
Nabumetone—Loss of consciousness—Prednisolone—atopic dermatitis	0.000121	0.000939	CcSEcCtD
Nabumetone—Vertigo—Hydrocortisone—atopic dermatitis	0.000121	0.000937	CcSEcCtD
Nabumetone—Syncope—Hydrocortisone—atopic dermatitis	0.000121	0.000936	CcSEcCtD
Nabumetone—Diarrhoea—Tacrolimus—atopic dermatitis	0.00012	0.000934	CcSEcCtD
Nabumetone—Hypertension—Prednisolone—atopic dermatitis	0.000119	0.000922	CcSEcCtD
Nabumetone—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000118	0.000917	CcSEcCtD
Nabumetone—Arrhythmia—Betamethasone—atopic dermatitis	0.000118	0.000915	CcSEcCtD
Nabumetone—Arrhythmia—Dexamethasone—atopic dermatitis	0.000118	0.000915	CcSEcCtD
Nabumetone—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.000117	0.000911	CcSEcCtD
Nabumetone—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.000117	0.000909	CcSEcCtD
Nabumetone—Alopecia—Dexamethasone—atopic dermatitis	0.000117	0.000905	CcSEcCtD
Nabumetone—Alopecia—Betamethasone—atopic dermatitis	0.000117	0.000905	CcSEcCtD
Nabumetone—Dizziness—Tacrolimus—atopic dermatitis	0.000116	0.000903	CcSEcCtD
Nabumetone—Hypertension—Hydrocortisone—atopic dermatitis	0.000116	0.000901	CcSEcCtD
Nabumetone—Discomfort—Prednisolone—atopic dermatitis	0.000116	0.000898	CcSEcCtD
Nabumetone—Angioedema—Triamcinolone—atopic dermatitis	0.000116	0.000898	CcSEcCtD
Nabumetone—Haemoglobin—Prednisone—atopic dermatitis	0.000115	0.000896	CcSEcCtD
Nabumetone—Angioedema—Methylprednisolone—atopic dermatitis	0.000115	0.000896	CcSEcCtD
Nabumetone—Haemorrhage—Prednisone—atopic dermatitis	0.000115	0.000892	CcSEcCtD
Nabumetone—Malaise—Triamcinolone—atopic dermatitis	0.000114	0.000886	CcSEcCtD
Nabumetone—Anxiety—Hydrocortisone—atopic dermatitis	0.000114	0.000885	CcSEcCtD
Nabumetone—MPO—IL23-mediated signaling events—IL6—atopic dermatitis	0.000114	0.0117	CbGpPWpGaD
Nabumetone—Malaise—Methylprednisolone—atopic dermatitis	0.000114	0.000884	CcSEcCtD
Nabumetone—Vertigo—Triamcinolone—atopic dermatitis	0.000114	0.000883	CcSEcCtD
Nabumetone—Syncope—Triamcinolone—atopic dermatitis	0.000114	0.000881	CcSEcCtD
Nabumetone—Vertigo—Methylprednisolone—atopic dermatitis	0.000113	0.000881	CcSEcCtD
Nabumetone—Syncope—Methylprednisolone—atopic dermatitis	0.000113	0.000879	CcSEcCtD
Nabumetone—Discomfort—Hydrocortisone—atopic dermatitis	0.000113	0.000878	CcSEcCtD
Nabumetone—PTGS2—Overview of nanoparticle effects—CXCL8—atopic dermatitis	0.000112	0.0116	CbGpPWpGaD
Nabumetone—Oedema—Prednisolone—atopic dermatitis	0.000112	0.000872	CcSEcCtD
Nabumetone—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000112	0.000872	CcSEcCtD
Nabumetone—Vomiting—Tacrolimus—atopic dermatitis	0.000112	0.000868	CcSEcCtD
Nabumetone—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000111	0.000863	CcSEcCtD
Nabumetone—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000111	0.000861	CcSEcCtD
Nabumetone—Rash—Tacrolimus—atopic dermatitis	0.000111	0.000861	CcSEcCtD
Nabumetone—Dermatitis—Tacrolimus—atopic dermatitis	0.000111	0.00086	CcSEcCtD
Nabumetone—Shock—Prednisolone—atopic dermatitis	0.000111	0.000858	CcSEcCtD
Nabumetone—Cough—Triamcinolone—atopic dermatitis	0.00011	0.000857	CcSEcCtD
Nabumetone—Headache—Tacrolimus—atopic dermatitis	0.00011	0.000855	CcSEcCtD
Nabumetone—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.00011	0.000851	CcSEcCtD
Nabumetone—Oedema—Hydrocortisone—atopic dermatitis	0.00011	0.000851	CcSEcCtD
Nabumetone—MPO—C-MYB transcription factor network—CD4—atopic dermatitis	0.000109	0.0113	CbGpPWpGaD
Nabumetone—MPO—Vitamin B12 Metabolism—TNF—atopic dermatitis	0.000109	0.0113	CbGpPWpGaD
Nabumetone—Hypertension—Triamcinolone—atopic dermatitis	0.000109	0.000848	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000109	0.0112	CbGpPWpGaD
Nabumetone—Hypertension—Methylprednisolone—atopic dermatitis	0.000109	0.000846	CcSEcCtD
Nabumetone—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000109	0.000843	CcSEcCtD
Nabumetone—Shock—Hydrocortisone—atopic dermatitis	0.000108	0.000838	CcSEcCtD
Nabumetone—Anxiety—Methylprednisolone—atopic dermatitis	0.000107	0.000832	CcSEcCtD
Nabumetone—Ill-defined disorder—Betamethasone—atopic dermatitis	0.000107	0.000827	CcSEcCtD
Nabumetone—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.000107	0.000827	CcSEcCtD
Nabumetone—Discomfort—Triamcinolone—atopic dermatitis	0.000106	0.000826	CcSEcCtD
Nabumetone—Discomfort—Methylprednisolone—atopic dermatitis	0.000106	0.000824	CcSEcCtD
Nabumetone—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000106	0.000823	CcSEcCtD
Nabumetone—Dry mouth—Triamcinolone—atopic dermatitis	0.000105	0.000818	CcSEcCtD
Nabumetone—Angioedema—Dexamethasone—atopic dermatitis	0.000105	0.000814	CcSEcCtD
Nabumetone—Angioedema—Betamethasone—atopic dermatitis	0.000105	0.000814	CcSEcCtD
Nabumetone—Anorexia—Hydrocortisone—atopic dermatitis	0.000105	0.000812	CcSEcCtD
Nabumetone—Nausea—Tacrolimus—atopic dermatitis	0.000104	0.000811	CcSEcCtD
Nabumetone—Confusional state—Methylprednisolone—atopic dermatitis	0.000104	0.000807	CcSEcCtD
Nabumetone—Malaise—Dexamethasone—atopic dermatitis	0.000104	0.000804	CcSEcCtD
Nabumetone—Malaise—Betamethasone—atopic dermatitis	0.000104	0.000804	CcSEcCtD
Nabumetone—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000103	0.000802	CcSEcCtD
Nabumetone—Oedema—Triamcinolone—atopic dermatitis	0.000103	0.000802	CcSEcCtD
Nabumetone—Vertigo—Betamethasone—atopic dermatitis	0.000103	0.000801	CcSEcCtD
Nabumetone—Vertigo—Dexamethasone—atopic dermatitis	0.000103	0.000801	CcSEcCtD
Nabumetone—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000103	0.0008	CcSEcCtD
Nabumetone—Syncope—Betamethasone—atopic dermatitis	0.000103	0.000799	CcSEcCtD
Nabumetone—Syncope—Dexamethasone—atopic dermatitis	0.000103	0.000799	CcSEcCtD
Nabumetone—Arrhythmia—Prednisone—atopic dermatitis	0.000103	0.000797	CcSEcCtD
Nabumetone—Shock—Triamcinolone—atopic dermatitis	0.000102	0.000789	CcSEcCtD
Nabumetone—Insomnia—Prednisolone—atopic dermatitis	0.000102	0.000788	CcSEcCtD
Nabumetone—Alopecia—Prednisone—atopic dermatitis	0.000102	0.000788	CcSEcCtD
Nabumetone—Shock—Methylprednisolone—atopic dermatitis	0.000101	0.000787	CcSEcCtD
Nabumetone—Loss of consciousness—Betamethasone—atopic dermatitis	0.000101	0.000783	CcSEcCtD
Nabumetone—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000101	0.000783	CcSEcCtD
Nabumetone—Paraesthesia—Prednisolone—atopic dermatitis	0.000101	0.000783	CcSEcCtD
Nabumetone—Hyperhidrosis—Triamcinolone—atopic dermatitis	9.99e-05	0.000775	CcSEcCtD
Nabumetone—Hyperhidrosis—Methylprednisolone—atopic dermatitis	9.96e-05	0.000773	CcSEcCtD
Nabumetone—Insomnia—Hydrocortisone—atopic dermatitis	9.92e-05	0.00077	CcSEcCtD
Nabumetone—Hypertension—Dexamethasone—atopic dermatitis	9.92e-05	0.00077	CcSEcCtD
Nabumetone—Hypertension—Betamethasone—atopic dermatitis	9.92e-05	0.00077	CcSEcCtD
Nabumetone—PTGS1—Overview of nanoparticle effects—TNF—atopic dermatitis	9.85e-05	0.0101	CbGpPWpGaD
Nabumetone—Paraesthesia—Hydrocortisone—atopic dermatitis	9.85e-05	0.000765	CcSEcCtD
Nabumetone—Anxiety—Betamethasone—atopic dermatitis	9.74e-05	0.000756	CcSEcCtD
Nabumetone—Anxiety—Dexamethasone—atopic dermatitis	9.74e-05	0.000756	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—IL1B—atopic dermatitis	9.74e-05	0.01	CbGpPWpGaD
Nabumetone—Discomfort—Dexamethasone—atopic dermatitis	9.66e-05	0.00075	CcSEcCtD
Nabumetone—Discomfort—Betamethasone—atopic dermatitis	9.66e-05	0.00075	CcSEcCtD
Nabumetone—Dyspepsia—Hydrocortisone—atopic dermatitis	9.66e-05	0.000749	CcSEcCtD
Nabumetone—Decreased appetite—Hydrocortisone—atopic dermatitis	9.54e-05	0.00074	CcSEcCtD
Nabumetone—Fatigue—Hydrocortisone—atopic dermatitis	9.46e-05	0.000734	CcSEcCtD
Nabumetone—Anaphylactic shock—Dexamethasone—atopic dermatitis	9.37e-05	0.000727	CcSEcCtD
Nabumetone—Oedema—Betamethasone—atopic dermatitis	9.37e-05	0.000727	CcSEcCtD
Nabumetone—Anaphylactic shock—Betamethasone—atopic dermatitis	9.37e-05	0.000727	CcSEcCtD
Nabumetone—Oedema—Dexamethasone—atopic dermatitis	9.37e-05	0.000727	CcSEcCtD
Nabumetone—Insomnia—Triamcinolone—atopic dermatitis	9.34e-05	0.000725	CcSEcCtD
Nabumetone—Insomnia—Methylprednisolone—atopic dermatitis	9.32e-05	0.000723	CcSEcCtD
Nabumetone—Ill-defined disorder—Prednisone—atopic dermatitis	9.28e-05	0.00072	CcSEcCtD
Nabumetone—Paraesthesia—Triamcinolone—atopic dermatitis	9.28e-05	0.00072	CcSEcCtD
Nabumetone—Feeling abnormal—Prednisolone—atopic dermatitis	9.26e-05	0.000718	CcSEcCtD
Nabumetone—Paraesthesia—Methylprednisolone—atopic dermatitis	9.26e-05	0.000718	CcSEcCtD
Nabumetone—Anaemia—Prednisone—atopic dermatitis	9.24e-05	0.000717	CcSEcCtD
Nabumetone—Shock—Betamethasone—atopic dermatitis	9.22e-05	0.000716	CcSEcCtD
Nabumetone—Shock—Dexamethasone—atopic dermatitis	9.22e-05	0.000716	CcSEcCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—atopic dermatitis	9.22e-05	0.0095	CbGpPWpGaD
Nabumetone—Dyspnoea—Triamcinolone—atopic dermatitis	9.21e-05	0.000715	CcSEcCtD
Nabumetone—Agitation—Prednisone—atopic dermatitis	9.19e-05	0.000713	CcSEcCtD
Nabumetone—Thrombocytopenia—Dexamethasone—atopic dermatitis	9.18e-05	0.000712	CcSEcCtD
Nabumetone—Thrombocytopenia—Betamethasone—atopic dermatitis	9.18e-05	0.000712	CcSEcCtD
Nabumetone—Angioedema—Prednisone—atopic dermatitis	9.14e-05	0.000709	CcSEcCtD
Nabumetone—Dyspepsia—Triamcinolone—atopic dermatitis	9.09e-05	0.000706	CcSEcCtD
Nabumetone—Dyspepsia—Methylprednisolone—atopic dermatitis	9.07e-05	0.000704	CcSEcCtD
Nabumetone—Hyperhidrosis—Dexamethasone—atopic dermatitis	9.06e-05	0.000703	CcSEcCtD
Nabumetone—Hyperhidrosis—Betamethasone—atopic dermatitis	9.06e-05	0.000703	CcSEcCtD
Nabumetone—Feeling abnormal—Hydrocortisone—atopic dermatitis	9.04e-05	0.000702	CcSEcCtD
Nabumetone—Malaise—Prednisone—atopic dermatitis	9.02e-05	0.0007	CcSEcCtD
Nabumetone—Vertigo—Prednisone—atopic dermatitis	8.99e-05	0.000697	CcSEcCtD
Nabumetone—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	8.97e-05	0.000696	CcSEcCtD
Nabumetone—Syncope—Prednisone—atopic dermatitis	8.97e-05	0.000696	CcSEcCtD
Nabumetone—Anorexia—Dexamethasone—atopic dermatitis	8.93e-05	0.000693	CcSEcCtD
Nabumetone—Anorexia—Betamethasone—atopic dermatitis	8.93e-05	0.000693	CcSEcCtD
Nabumetone—Urticaria—Prednisolone—atopic dermatitis	8.92e-05	0.000693	CcSEcCtD
Nabumetone—Fatigue—Triamcinolone—atopic dermatitis	8.91e-05	0.000691	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—TNF—atopic dermatitis	8.89e-05	0.00916	CbGpPWpGaD
Nabumetone—Fatigue—Methylprednisolone—atopic dermatitis	8.89e-05	0.00069	CcSEcCtD
Nabumetone—MPO—Vitamin B12 Metabolism—IL6—atopic dermatitis	8.82e-05	0.00908	CbGpPWpGaD
Nabumetone—Loss of consciousness—Prednisone—atopic dermatitis	8.79e-05	0.000682	CcSEcCtD
Nabumetone—Urticaria—Hydrocortisone—atopic dermatitis	8.72e-05	0.000676	CcSEcCtD
Nabumetone—Abdominal pain—Hydrocortisone—atopic dermatitis	8.67e-05	0.000673	CcSEcCtD
Nabumetone—Body temperature increased—Hydrocortisone—atopic dermatitis	8.67e-05	0.000673	CcSEcCtD
Nabumetone—Hypertension—Prednisone—atopic dermatitis	8.63e-05	0.00067	CcSEcCtD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—atopic dermatitis	8.62e-05	0.00888	CbGpPWpGaD
Nabumetone—Feeling abnormal—Triamcinolone—atopic dermatitis	8.51e-05	0.000661	CcSEcCtD
Nabumetone—Feeling abnormal—Methylprednisolone—atopic dermatitis	8.49e-05	0.000659	CcSEcCtD
Nabumetone—Anxiety—Prednisone—atopic dermatitis	8.49e-05	0.000659	CcSEcCtD
Nabumetone—Insomnia—Betamethasone—atopic dermatitis	8.48e-05	0.000658	CcSEcCtD
Nabumetone—Insomnia—Dexamethasone—atopic dermatitis	8.48e-05	0.000658	CcSEcCtD
Nabumetone—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	8.43e-05	0.000654	CcSEcCtD
Nabumetone—Paraesthesia—Betamethasone—atopic dermatitis	8.42e-05	0.000653	CcSEcCtD
Nabumetone—Paraesthesia—Dexamethasone—atopic dermatitis	8.42e-05	0.000653	CcSEcCtD
Nabumetone—Discomfort—Prednisone—atopic dermatitis	8.41e-05	0.000653	CcSEcCtD
Nabumetone—Hypersensitivity—Prednisolone—atopic dermatitis	8.28e-05	0.000642	CcSEcCtD
Nabumetone—Dyspepsia—Betamethasone—atopic dermatitis	8.25e-05	0.00064	CcSEcCtD
Nabumetone—Dyspepsia—Dexamethasone—atopic dermatitis	8.25e-05	0.00064	CcSEcCtD
Nabumetone—Urticaria—Triamcinolone—atopic dermatitis	8.21e-05	0.000637	CcSEcCtD
Nabumetone—Urticaria—Methylprednisolone—atopic dermatitis	8.19e-05	0.000635	CcSEcCtD
Nabumetone—Body temperature increased—Triamcinolone—atopic dermatitis	8.17e-05	0.000634	CcSEcCtD
Nabumetone—Anaphylactic shock—Prednisone—atopic dermatitis	8.16e-05	0.000633	CcSEcCtD
Nabumetone—Oedema—Prednisone—atopic dermatitis	8.16e-05	0.000633	CcSEcCtD
Nabumetone—Abdominal pain—Methylprednisolone—atopic dermatitis	8.15e-05	0.000632	CcSEcCtD
Nabumetone—Decreased appetite—Dexamethasone—atopic dermatitis	8.15e-05	0.000632	CcSEcCtD
Nabumetone—Decreased appetite—Betamethasone—atopic dermatitis	8.15e-05	0.000632	CcSEcCtD
Nabumetone—Hypersensitivity—Hydrocortisone—atopic dermatitis	8.08e-05	0.000627	CcSEcCtD
Nabumetone—Fatigue—Dexamethasone—atopic dermatitis	8.08e-05	0.000627	CcSEcCtD
Nabumetone—Fatigue—Betamethasone—atopic dermatitis	8.08e-05	0.000627	CcSEcCtD
Nabumetone—Shock—Prednisone—atopic dermatitis	8.03e-05	0.000623	CcSEcCtD
Nabumetone—PTGS1—Overview of nanoparticle effects—IL6—atopic dermatitis	7.95e-05	0.00819	CbGpPWpGaD
Nabumetone—Hyperhidrosis—Prednisone—atopic dermatitis	7.89e-05	0.000612	CcSEcCtD
Nabumetone—Asthenia—Hydrocortisone—atopic dermatitis	7.87e-05	0.000611	CcSEcCtD
Nabumetone—PTGS2—Overview of nanoparticle effects—TNF—atopic dermatitis	7.82e-05	0.00806	CbGpPWpGaD
Nabumetone—Anorexia—Prednisone—atopic dermatitis	7.78e-05	0.000604	CcSEcCtD
Nabumetone—Pruritus—Hydrocortisone—atopic dermatitis	7.76e-05	0.000602	CcSEcCtD
Nabumetone—Feeling abnormal—Betamethasone—atopic dermatitis	7.72e-05	0.000599	CcSEcCtD
Nabumetone—Feeling abnormal—Dexamethasone—atopic dermatitis	7.72e-05	0.000599	CcSEcCtD
Nabumetone—Gastrointestinal pain—Betamethasone—atopic dermatitis	7.66e-05	0.000595	CcSEcCtD
Nabumetone—Gastrointestinal pain—Dexamethasone—atopic dermatitis	7.66e-05	0.000595	CcSEcCtD
Nabumetone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—atopic dermatitis	7.66e-05	0.00789	CbGpPWpGaD
Nabumetone—Hypersensitivity—Triamcinolone—atopic dermatitis	7.61e-05	0.000591	CcSEcCtD
Nabumetone—Hypersensitivity—Methylprednisolone—atopic dermatitis	7.59e-05	0.000589	CcSEcCtD
Nabumetone—Diarrhoea—Hydrocortisone—atopic dermatitis	7.51e-05	0.000583	CcSEcCtD
Nabumetone—Urticaria—Dexamethasone—atopic dermatitis	7.45e-05	0.000578	CcSEcCtD
Nabumetone—Urticaria—Betamethasone—atopic dermatitis	7.45e-05	0.000578	CcSEcCtD
Nabumetone—Dizziness—Prednisolone—atopic dermatitis	7.43e-05	0.000576	CcSEcCtD
Nabumetone—Asthenia—Triamcinolone—atopic dermatitis	7.41e-05	0.000575	CcSEcCtD
Nabumetone—Abdominal pain—Betamethasone—atopic dermatitis	7.41e-05	0.000575	CcSEcCtD
Nabumetone—Body temperature increased—Betamethasone—atopic dermatitis	7.41e-05	0.000575	CcSEcCtD
Nabumetone—Abdominal pain—Dexamethasone—atopic dermatitis	7.41e-05	0.000575	CcSEcCtD
Nabumetone—Body temperature increased—Dexamethasone—atopic dermatitis	7.41e-05	0.000575	CcSEcCtD
Nabumetone—Asthenia—Methylprednisolone—atopic dermatitis	7.4e-05	0.000574	CcSEcCtD
Nabumetone—Insomnia—Prednisone—atopic dermatitis	7.38e-05	0.000573	CcSEcCtD
Nabumetone—Paraesthesia—Prednisone—atopic dermatitis	7.33e-05	0.000569	CcSEcCtD
Nabumetone—Pruritus—Triamcinolone—atopic dermatitis	7.31e-05	0.000567	CcSEcCtD
Nabumetone—Pruritus—Methylprednisolone—atopic dermatitis	7.29e-05	0.000566	CcSEcCtD
Nabumetone—Dizziness—Hydrocortisone—atopic dermatitis	7.25e-05	0.000563	CcSEcCtD
Nabumetone—Dyspepsia—Prednisone—atopic dermatitis	7.19e-05	0.000558	CcSEcCtD
Nabumetone—MPO—Folate Metabolism—IL6—atopic dermatitis	7.18e-05	0.00739	CbGpPWpGaD
Nabumetone—Decreased appetite—Prednisone—atopic dermatitis	7.1e-05	0.000551	CcSEcCtD
Nabumetone—Rash—Prednisolone—atopic dermatitis	7.08e-05	0.00055	CcSEcCtD
Nabumetone—Dermatitis—Prednisolone—atopic dermatitis	7.08e-05	0.000549	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—TNF—atopic dermatitis	7.06e-05	0.00728	CbGpPWpGaD
Nabumetone—Diarrhoea—Methylprednisolone—atopic dermatitis	7.05e-05	0.000547	CcSEcCtD
Nabumetone—Fatigue—Prednisone—atopic dermatitis	7.04e-05	0.000546	CcSEcCtD
Nabumetone—Headache—Prednisolone—atopic dermatitis	7.04e-05	0.000546	CcSEcCtD
Nabumetone—Constipation—Prednisone—atopic dermatitis	6.98e-05	0.000542	CcSEcCtD
Nabumetone—Vomiting—Hydrocortisone—atopic dermatitis	6.98e-05	0.000541	CcSEcCtD
Nabumetone—Rash—Hydrocortisone—atopic dermatitis	6.92e-05	0.000537	CcSEcCtD
Nabumetone—Dermatitis—Hydrocortisone—atopic dermatitis	6.91e-05	0.000536	CcSEcCtD
Nabumetone—Headache—Hydrocortisone—atopic dermatitis	6.87e-05	0.000533	CcSEcCtD
Nabumetone—Dizziness—Triamcinolone—atopic dermatitis	6.83e-05	0.00053	CcSEcCtD
Nabumetone—Dizziness—Methylprednisolone—atopic dermatitis	6.82e-05	0.000529	CcSEcCtD
Nabumetone—Feeling abnormal—Prednisone—atopic dermatitis	6.73e-05	0.000522	CcSEcCtD
Nabumetone—Asthenia—Dexamethasone—atopic dermatitis	6.72e-05	0.000522	CcSEcCtD
Nabumetone—Asthenia—Betamethasone—atopic dermatitis	6.72e-05	0.000522	CcSEcCtD
Nabumetone—Gastrointestinal pain—Prednisone—atopic dermatitis	6.67e-05	0.000518	CcSEcCtD
Nabumetone—Nausea—Prednisolone—atopic dermatitis	6.67e-05	0.000518	CcSEcCtD
Nabumetone—Pruritus—Betamethasone—atopic dermatitis	6.63e-05	0.000515	CcSEcCtD
Nabumetone—Pruritus—Dexamethasone—atopic dermatitis	6.63e-05	0.000515	CcSEcCtD
Nabumetone—Vomiting—Triamcinolone—atopic dermatitis	6.57e-05	0.00051	CcSEcCtD
Nabumetone—Vomiting—Methylprednisolone—atopic dermatitis	6.55e-05	0.000509	CcSEcCtD
Nabumetone—Nausea—Hydrocortisone—atopic dermatitis	6.52e-05	0.000506	CcSEcCtD
Nabumetone—Rash—Triamcinolone—atopic dermatitis	6.51e-05	0.000505	CcSEcCtD
Nabumetone—Dermatitis—Triamcinolone—atopic dermatitis	6.51e-05	0.000505	CcSEcCtD
Nabumetone—Rash—Methylprednisolone—atopic dermatitis	6.5e-05	0.000504	CcSEcCtD
Nabumetone—Dermatitis—Methylprednisolone—atopic dermatitis	6.49e-05	0.000504	CcSEcCtD
Nabumetone—Urticaria—Prednisone—atopic dermatitis	6.48e-05	0.000503	CcSEcCtD
Nabumetone—Headache—Triamcinolone—atopic dermatitis	6.47e-05	0.000502	CcSEcCtD
Nabumetone—Headache—Methylprednisolone—atopic dermatitis	6.46e-05	0.000501	CcSEcCtD
Nabumetone—Abdominal pain—Prednisone—atopic dermatitis	6.45e-05	0.000501	CcSEcCtD
Nabumetone—Body temperature increased—Prednisone—atopic dermatitis	6.45e-05	0.000501	CcSEcCtD
Nabumetone—Diarrhoea—Betamethasone—atopic dermatitis	6.41e-05	0.000498	CcSEcCtD
Nabumetone—Diarrhoea—Dexamethasone—atopic dermatitis	6.41e-05	0.000498	CcSEcCtD
Nabumetone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	6.33e-05	0.00652	CbGpPWpGaD
Nabumetone—PTGS2—Overview of nanoparticle effects—IL6—atopic dermatitis	6.31e-05	0.0065	CbGpPWpGaD
Nabumetone—Dizziness—Dexamethasone—atopic dermatitis	6.2e-05	0.000481	CcSEcCtD
Nabumetone—Dizziness—Betamethasone—atopic dermatitis	6.2e-05	0.000481	CcSEcCtD
Nabumetone—Nausea—Triamcinolone—atopic dermatitis	6.14e-05	0.000476	CcSEcCtD
Nabumetone—Nausea—Methylprednisolone—atopic dermatitis	6.12e-05	0.000475	CcSEcCtD
Nabumetone—Hypersensitivity—Prednisone—atopic dermatitis	6.01e-05	0.000467	CcSEcCtD
Nabumetone—Vomiting—Dexamethasone—atopic dermatitis	5.96e-05	0.000463	CcSEcCtD
Nabumetone—Vomiting—Betamethasone—atopic dermatitis	5.96e-05	0.000463	CcSEcCtD
Nabumetone—Rash—Dexamethasone—atopic dermatitis	5.91e-05	0.000459	CcSEcCtD
Nabumetone—Rash—Betamethasone—atopic dermatitis	5.91e-05	0.000459	CcSEcCtD
Nabumetone—Dermatitis—Betamethasone—atopic dermatitis	5.9e-05	0.000458	CcSEcCtD
Nabumetone—Dermatitis—Dexamethasone—atopic dermatitis	5.9e-05	0.000458	CcSEcCtD
Nabumetone—Headache—Betamethasone—atopic dermatitis	5.87e-05	0.000456	CcSEcCtD
Nabumetone—Headache—Dexamethasone—atopic dermatitis	5.87e-05	0.000456	CcSEcCtD
Nabumetone—Asthenia—Prednisone—atopic dermatitis	5.86e-05	0.000455	CcSEcCtD
Nabumetone—Pruritus—Prednisone—atopic dermatitis	5.78e-05	0.000448	CcSEcCtD
Nabumetone—MPO—Selenium Micronutrient Network—IL6—atopic dermatitis	5.7e-05	0.00587	CbGpPWpGaD
Nabumetone—Diarrhoea—Prednisone—atopic dermatitis	5.58e-05	0.000433	CcSEcCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—atopic dermatitis	5.57e-05	0.00574	CbGpPWpGaD
Nabumetone—Nausea—Dexamethasone—atopic dermatitis	5.57e-05	0.000432	CcSEcCtD
Nabumetone—Nausea—Betamethasone—atopic dermatitis	5.57e-05	0.000432	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—CXCL10—atopic dermatitis	5.56e-05	0.00573	CbGpPWpGaD
Nabumetone—Dizziness—Prednisone—atopic dermatitis	5.4e-05	0.000419	CcSEcCtD
Nabumetone—Vomiting—Prednisone—atopic dermatitis	5.19e-05	0.000403	CcSEcCtD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atopic dermatitis	5.18e-05	0.00534	CbGpPWpGaD
Nabumetone—Rash—Prednisone—atopic dermatitis	5.15e-05	0.000399	CcSEcCtD
Nabumetone—Dermatitis—Prednisone—atopic dermatitis	5.14e-05	0.000399	CcSEcCtD
Nabumetone—Headache—Prednisone—atopic dermatitis	5.11e-05	0.000397	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—BDNF—atopic dermatitis	5e-05	0.00515	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—atopic dermatitis	4.95e-05	0.0051	CbGpPWpGaD
Nabumetone—Nausea—Prednisone—atopic dermatitis	4.85e-05	0.000376	CcSEcCtD
Nabumetone—PTGS2—Spinal Cord Injury—IL4—atopic dermatitis	4.64e-05	0.00478	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	4.56e-05	0.0047	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IFNG—atopic dermatitis	4.47e-05	0.0046	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL1B—atopic dermatitis	3.98e-05	0.0041	CbGpPWpGaD
Nabumetone—PTGS2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	3.86e-05	0.00397	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	3.62e-05	0.00373	CbGpPWpGaD
Nabumetone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atopic dermatitis	3.61e-05	0.00372	CbGpPWpGaD
Nabumetone—PTGS2—C-MYB transcription factor network—CD4—atopic dermatitis	3.55e-05	0.00366	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IFNG—atopic dermatitis	3.55e-05	0.00365	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	3.4e-05	0.0035	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	3.37e-05	0.00347	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL1B—atopic dermatitis	3.16e-05	0.00326	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	3.01e-05	0.0031	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	3e-05	0.00309	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—TNF—atopic dermatitis	2.89e-05	0.00298	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IFNG—atopic dermatitis	2.8e-05	0.00289	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—CXCL8—atopic dermatitis	2.61e-05	0.00269	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL1B—atopic dermatitis	2.5e-05	0.00258	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL2—atopic dermatitis	2.49e-05	0.00257	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	2.49e-05	0.00256	CbGpPWpGaD
Nabumetone—PTGS1—Selenium Micronutrient Network—IL6—atopic dermatitis	2.33e-05	0.0024	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—TNF—atopic dermatitis	2.29e-05	0.00236	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	2.24e-05	0.00231	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	2.18e-05	0.00225	CbGpPWpGaD
Nabumetone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	2.18e-05	0.00225	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	2.05e-05	0.00211	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—GLB1—atopic dermatitis	2.03e-05	0.00209	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—ADSL—atopic dermatitis	1.95e-05	0.002	CbGpPWpGaD
Nabumetone—PTGS2—Disease—GLB1—atopic dermatitis	1.92e-05	0.00198	CbGpPWpGaD
Nabumetone—PTGS2—Selenium Micronutrient Network—IL6—atopic dermatitis	1.85e-05	0.00191	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—TNF—atopic dermatitis	1.81e-05	0.00187	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—GLB1—atopic dermatitis	1.61e-05	0.00166	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.56e-05	0.00161	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—ADSL—atopic dermatitis	1.55e-05	0.00159	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.48e-05	0.00152	CbGpPWpGaD
Nabumetone—PTGS2—Spinal Cord Injury—IL6—atopic dermatitis	1.46e-05	0.00151	CbGpPWpGaD
Nabumetone—PTGS2—Disease—SLC11A1—atopic dermatitis	1.29e-05	0.00133	CbGpPWpGaD
Nabumetone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.23e-05	0.00127	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.17e-05	0.00121	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—GLB1—atopic dermatitis	9.12e-06	0.000939	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—ADSL—atopic dermatitis	8.74e-06	0.000901	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.65e-06	0.000685	CbGpPWpGaD
Nabumetone—PTGS1—Metabolism—PPARA—atopic dermatitis	6.59e-06	0.000679	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CCR5—atopic dermatitis	6.51e-06	0.000671	CbGpPWpGaD
Nabumetone—PTGS2—Metabolism—PPARA—atopic dermatitis	5.23e-06	0.000539	CbGpPWpGaD
Nabumetone—PTGS2—Disease—CD4—atopic dermatitis	4.09e-06	0.000421	CbGpPWpGaD
Nabumetone—CYP1A2—Metabolism—PPARA—atopic dermatitis	2.96e-06	0.000305	CbGpPWpGaD
Nabumetone—PTGS2—Disease—IL6—atopic dermatitis	2.21e-06	0.000228	CbGpPWpGaD
